TherapeuticsMD Inc Watch

from 8-K 93 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Agreement and Plan of Merger by and Among: Athene Parent, Inc. Athene Merger Sub, Inc. and Therapeuticsmd, Inc. Dated as of May 27, 2022

from 8-K 89 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(2). Such Excluded Information Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Stock Purchase Agreement by and Between Goodrx, Inc., and Therapeuticsmd, Inc. With Respect to Purchase of All the Outstanding Capital Stock of Vitacare Prescription Services, Inc. Dated as of March 6, 2022

from 8-K 25 pages Agreement and Plan of Reorganization Among Croff Enterprises, Inc., Amhn Acquisition Corp., America’s Minority Health Network, Inc. and the Major Shareholders Listed on Schedule a Hereto Agreement and Plan of Reorganization

from 10-Q 11 pages Croff Enterprises, Inc. Plan of Corporate Division and Reorganization October 25, 2007

from 8-K/A 1 page Plan of reorganization, merger, acquisition or similar

from SC TO-T/A 1 page Thank You. Very Truly Yours, By: Colleen Jensen, Secretary Jensen Development Company

from SC TO-T/A 1 page Thank You. Very Truly Yours, By: Colleen Jensen, Secretary Jensen Development Company

from SC TO-T/A ~5 pages Letter of Transmittal to Tender Shares of the Class B Preferred Shares of Croff Enterprises, Inc. Tendered Pursuant to the Offer to Purchase Dated July 15, 2005

from SC 14D9 1 page The Four Directors Comprising the Non-Management Committee of the Croff Board of Directors Unanimously Believe That a Tender Offer Is a Good Alternative, From a Financial Perspective, for the Croff Preferred B Shareholders Generally, at This Time. the Same Directors Also Unanimously Believe That Each Preferred B Shareholder Should Decide Whether or Not to Tender Shares in This Tender Offer Based Upon Their Specific Situation and Investment Objectives. Therefore, the Non-Management Committee Makes No Recommendation for or Against This Tender Offer. for Your Information, Each Director on the Non-Management Committee Has Expressed an Inclination to Tender All or Part of His Shares in This Tender Offer. Very Truly Yours, /S/ Dilworth A. Nebeker Dilworth A. Nebeker Acting Lead Director Croff Enterprises, Inc

from SC TO-T/A ~5 pages Letter of Transmittal to Tender Shares of the Class B Preferred Shares of Croff Enterprises, Inc. Tendered Pursuant to the Offer to Purchase Dated July 5, 2005

from SC TO-T/A ~5 pages Letter of Transmittal to Tender Shares of the Class B Preferred Shares of Croff Enterprises, Inc. Tendered Pursuant to the Offer to Purchase Dated June 28, 2005